Anteo Diagnostics Ltd has released a press release.
Strategic Review Outcomes
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AnteoTech
- Appointment of Interim CEO
- Half Year Results and Operational Update Presentation
- Results of Entitlement Offer
- Life Sciences Update
- Chair's Address to Shareholders
Later from AnteoTech
- AnteoBind Order Received and Life Sciences Update
- Key Technical Milestone Achieved for Ultranode
- Agreement for combined Anteo X product in the USA
- $2.59 million R&D Tax Incentive received
- Queensland Government Grant Funding Update
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech